AAAAAA

   
Results: 1-24 |
Results: 24
The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia
Authors: Marsh, A Spurdle, AB Turner, BC Fereday, S Thorne, H Pupo, GM Mann, GJ Hopper, JL Sambrook, JF Chenevix-Trench, G
Citation: A. Marsh et al., The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia, BREAST CA R, 3(5), 2001, pp. 346-349
A single nucleotide polymorphism in the 5 ' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers
Authors: Wang, WW Spurdle, AB Kolachana, P Bove, B Modan, B Ebbers, SM Suthers, G Tucker, MA Kaufman, DJ Doody, MM Tarone, RE Daly, M Levavi, H Pierce, H Chetrit, A Yechezkel, GH Chenevix-Trench, G Offit, K Godwin, AK Struewing, JP
Citation: Ww. Wang et al., A single nucleotide polymorphism in the 5 ' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers, CANC EPID B, 10(9), 2001, pp. 955-960
The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer
Authors: Spurdle, AB Purdie, DM Webb, PM Chen, XQ Green, A Chenevix-Trench, G
Citation: Ab. Spurdle et al., The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer, MOL CARCINO, 30(1), 2001, pp. 71-78
No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer
Authors: Spurdle, AB Webb, PM Purdie, DM Chen, XQ Green, A Chenevix-Trench, G
Citation: Ab. Spurdle et al., No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer, CARCINOGENE, 22(5), 2001, pp. 717-721
Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype
Authors: Spurdle, AB Webb, PM Purdie, DM Chen, XQ Green, A Chenevix-Trench, G
Citation: Ab. Spurdle et al., Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype, CARCINOGENE, 22(1), 2001, pp. 67-72
Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas
Authors: Arnold, JM Cummings, M Purdie, D Chenevix-Trench, G
Citation: Jm. Arnold et al., Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas, BR J CANC, 85(9), 2001, pp. 1351-1358
Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma
Authors: Francis-Thickpenny, KM Richardson, DM van Ee, CC Love, DR Winship, IM Baguley, BC Chenevix-Trench, G Shelling, AN
Citation: Km. Francis-thickpenny et al., Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma, BR J CANC, 85(5), 2001, pp. 687-691
Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas
Authors: Arnold, JM Mok, SC Purdie, D Chenevix-Trench, G
Citation: Jm. Arnold et al., Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas, BR J CANC, 84(3), 2001, pp. 352-359
CYP17 promoter polymorphism and breast cancer in Australian women under age forty years
Authors: Spurdle, AB Hopper, JL Dite, GS Chen, XQ Cui, JS McCredie, MRE Giles, GG Southey, MC Venter, DJ Easton, DF Chenevix-Trench, G
Citation: Ab. Spurdle et al., CYP17 promoter polymorphism and breast cancer in Australian women under age forty years, J NAT CANC, 92(20), 2000, pp. 1674-1681
The spectrum of patched mutations in a collection of Australian basal cellcarcinomas
Authors: Evans, T Boonchai, W Shanley, S Smyth, I Gillies, S Georgas, K Wainwright, B Chenevix-Trench, G Wicking, C
Citation: T. Evans et al., The spectrum of patched mutations in a collection of Australian basal cellcarcinomas, HUM MUTAT, 16(1), 2000, pp. 43-48
Sequence variants of DLC1 in colorectal and ovarian tumours
Authors: Wilson, PJ McGlinn, E Marsh, A Evans, T Arnold, J Wright, K Biden, K Young, J Wainwright, B Wicking, C Chenevix-Trench, G
Citation: Pj. Wilson et al., Sequence variants of DLC1 in colorectal and ovarian tumours, HUM MUTAT, 15(2), 2000, pp. 156-165
Evidence for microsatellite instability in bilateral breast carcinomas
Authors: Imyanitov, EN Togo, AV Suspitsin, EN Grigoriev, MY Pozharisski, KM Turkevich, EA Hanson, KP Hayward, NK Chenevix-Trench, G Theillet, C Lavin, MF
Citation: En. Imyanitov et al., Evidence for microsatellite instability in bilateral breast carcinomas, CANCER LETT, 154(1), 2000, pp. 9-17
Basal cell carcinoma in chronic arsenicism occurring in Queensland, Australia, after ingestion of an asthma medication
Authors: Boonchai, W Green, A Ng, J Dicker, A Chenevix-Trench, G
Citation: W. Boonchai et al., Basal cell carcinoma in chronic arsenicism occurring in Queensland, Australia, after ingestion of an asthma medication, J AM ACAD D, 43(4), 2000, pp. 664-669
Tumour-specific distribution of BRCA1 promoter region methylation supportsa pathogenetic role in breast and ovarian cancer
Authors: Bianco, T Chenevix-Trench, G Walsh, DCA Cooper, JE Dobrovic, A
Citation: T. Bianco et al., Tumour-specific distribution of BRCA1 promoter region methylation supportsa pathogenetic role in breast and ovarian cancer, CARCINOGENE, 21(2), 2000, pp. 147-151
kConFab: a research resource of Australasian breast cancer families
Authors: Osborne, RH Hopper, JL Kirk, JA Chenevix-Trench, G Thorne, HJ Sambrook, JF
Citation: Rh. Osborne et al., kConFab: a research resource of Australasian breast cancer families, MED J AUST, 172(9), 2000, pp. 463-464
Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer
Authors: Spurdle, AB Webb, PM Chen, XQ Martin, NG Giles, GG Hopper, JL Chenevix-Trench, G
Citation: Ab. Spurdle et al., Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer, INT J CANC, 87(5), 2000, pp. 637-643
CYP17 promotor polymorphism and ovarian cancer risk
Authors: Spurdle, AB Chen, XQ Abbazadegan, M Martin, N Khoo, SK Hurst, T Ward, B Webb, PM Chenevix-Trench, G
Citation: Ab. Spurdle et al., CYP17 promotor polymorphism and ovarian cancer risk, INT J CANC, 86(3), 2000, pp. 436-439
Expression at beta-catenin, a key mediator of the WNT signaling pathway, in basal cell carcinoma
Authors: Boonchai, W Walsh, M Cummings, M Chenevix-Trench, G
Citation: W. Boonchai et al., Expression at beta-catenin, a key mediator of the WNT signaling pathway, in basal cell carcinoma, ARCH DERMAT, 136(7), 2000, pp. 937-938
Expression of p53 in arsenic-related and sporadic basal cell carcinoma
Authors: Boonchai, W Walsh, M Cummings, M Chenevix-Trench, G
Citation: W. Boonchai et al., Expression of p53 in arsenic-related and sporadic basal cell carcinoma, ARCH DERMAT, 136(2), 2000, pp. 195-198
Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years
Authors: Spurdle, AB Dite, GS Chen, XQ Mayne, CJ Southey, MC Batten, LE Chy, H Trute, L McCredie, MRE Giles, GG Armes, J Venter, DJ Hopper, JL Chenevix-Trench, G
Citation: Ab. Spurdle et al., Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years, J NAT CANC, 91(11), 1999, pp. 961-966
Isolation and characterization of human Patched 2 (PTCH2), a putative tumour suppressor gene in basal cell carcinoma and medulloblastoma on chromosome 1p32
Authors: Smyth, I Narang, MA Evans, T Heimann, C Nakamura, Y Chenevix-Trench, G Pietsch, T Wicking, C Wainwright, BJ
Citation: I. Smyth et al., Isolation and characterization of human Patched 2 (PTCH2), a putative tumour suppressor gene in basal cell carcinoma and medulloblastoma on chromosome 1p32, HUM MOL GEN, 8(2), 1999, pp. 291-297
Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but thegene encoding p73 is unlikely to be the target
Authors: Imyanitov, EN Birrell, GW Filippovich, I Sorokina, N Arnold, J Mould, MA Wright, K Walsh, M Mok, SC Lavin, MF Chenevix-Trench, G Khanna, KK
Citation: En. Imyanitov et al., Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but thegene encoding p73 is unlikely to be the target, ONCOGENE, 18(32), 1999, pp. 4640-4642
Assignment of the human slit homologue SLIT2 to human chromosome band 4p15.2
Authors: Georgas, K Burridge, L Smith, K Holmes, GP Chenevix-Trench, G Ioannou, PA Little, MH
Citation: K. Georgas et al., Assignment of the human slit homologue SLIT2 to human chromosome band 4p15.2, CYTOG C GEN, 86(3-4), 1999, pp. 246-247
beta-catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumours
Authors: Wright, K Wilson, P Morland, S Campbell, I Walsh, M Hurst, T Ward, B Cummings, M Chenevix-Trench, G
Citation: K. Wright et al., beta-catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumours, INT J CANC, 82(5), 1999, pp. 625-629
Risultati: 1-24 |